1. Agronin ME. Practical guide in psychiatry. 1st ed. Philadelphia: Lippincott Co. 2004; P. 72-280.

2. Hebert LE, Weuve J, Scherr PA, Evans DA. Alzheimer disease in the United States (2010-2050) estimated using the 2010 census. Neurology. 2013; 80(19): 1778-83. [DOI:10.1212/WNL.0b013e31828726f5]

3. Rovner BW. Depression and increased risk of mortality in nursing home patient. Am J Med. 1993; 94(5A): 19S-22S.

4. Mitchell AJ, Subramaniam H. Prognosis of depression in old age compared to middle ages: A systematic review of comparative studies. Am J Psychiatry. 2005; 162: 1588-601. [DOI:10.1176/appi.ajp.162.9.1588]

5. Reynolds C, Kupfer D. Depression and aging: A look to the future. Psychiatric Services. 1999; 50(9): 1167-72. [DOI:10.1176/ps.50.9.1167]

6. Tsuno N, Homma A. What is the association between depression and Alzheimer's disease? Expert Rev Neurother. 2009; 9(11): 1667-76. [DOI:10.1586/ern.09.106]

7. Lyketsos CG, Lee HB. Diagnosis and treatment of depression in Alzheimer's disease. A practical update for the clinician. Dement Geriatr Cogn Disord. 2004; 17(1-2): 55-64. [DOI:10.1159/000074277]

8. Lyketsos CG, Olin j. Depression in Alzheimer disease: overview and treatment. Biol Psychiatry. 2002; 52(3): 242-53. [DOI:10.1016/S0006-3223(02)01348-3]

9. Zubenko G, Zubenko W, McPherson S, Spoor E, Marin D, Farlow M, et al. A collaborative study of the emergence and clinical features of the major depressive syndrome of Alzheimer's disease. Am J Psychiatry. 2003; 160(5): 857-66. [DOI:10.1176/appi.ajp.160.5.857]

10. Forsell Y, Jorm A, Winblad B. Variation in psychiatric and behavioural symptoms at different stages of dementia: data from physicians' examinations and informants' reports. Dementia. 1993; 4(5): 282-6. [DOI:10.1159/000107334]

11. Payne J, Lyketsos C, Steele C, Baker L, Galik E, Kopunek S, et al. Relationship of cognitive and functional impairment to depressive features in Alzheimer's disease and other dementias. J Neuropsychiatry Clin Neurosci. 1998; 10(4): 440-7. [DOI:10.1176/jnp.10.4.440]

12. Salmon E, Perani D, Collette F, Feyers D, Kalbe E, Holthoff V, et al. A comparison of unawareness in frontotemporal dementia and Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2008; 79(2): 176-9. [DOI:10.1136/jnnp.2007.122853]

13. Gonzalez- Salvador T, Lyktesos CG, Baker A, Hovanec L, Roques C, Brandt J, et al. Quality of life in dementia patiants in long term care. Int J Geriatr Psychiatry. 2000; 15(2): 181-9. https://doi.org/10.1002/(SICI)1099-1166(200002)15:2<181::AID-GPS96>3.0.CO;2-I [DOI:10.1002/(SICI)1099-1166(200002)15:23.0.CO;2-I]

14. Forstle H, Burns A, Lathert P, Carins N, Lantos P, Levy R. Clinical and nerupsychological correlates of depression in Alzhiemer diseases. Psychol Med. 1992; 22(4): 877-84. [DOI:10.1017/S0033291700038459]

15. Zubenko G, Moossy J, Kopp U. Neurochemical correlates of major depression in primary dementia. Arch Neurol. 1990; 47(2): 209-14. [DOI:10.1001/archneur.1990.00530020117023]

16. Ownby RL, Crocco EL, Acevedo A, Vineeth J, Loewenstein D. Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis. Arch Gen Psychiatry. 2006; 63(5): 530-8. [DOI:10.1001/archpsyc.63.5.530]

17. Kokmen E. The eurodem collaborative re-analysis of case-control studies of alzheimer's disease: implications for clinical research and practice. Int J Epidemiol. 1991; 20(2): S65-S67. [DOI:10.1093/ije/20.Supplement_2.S65]

18. Tsolaki M, Fountoulakis K, Chantzi E, Kazis A. Risk factors for clinically diagnosed alzheimers disease: a case-control study of a greek population. Int Psychogeriatr. 1997; 9(3): 327-41. [DOI:10.1017/S104161029700447X]

19. Almeida O, Hankey G, Yeap B, Golledge J, Flicker L. Depression as a modifiable factor to decrease the risk of dementia. Transl Psychiatry. 2017; 7(5): e1117. doi: 10.1038/tp.2017.90. [DOI:10.1038/tp.2017.90]

20. Lindsay J, Laurin D, Verreault R, Hébert R, Helliwell B, Hill GB, et al. Risk factors for alzheimer's disease: a prospective analysis from the canadian study of health and aging. Am J Epidemiol. 2002; 156(5): 445-53. [DOI:10.1093/aje/kwf074]

21. Broe GA, Henderson AS, Creasey H, McCusker E, Korten AE, Jorm AF, et al. A case‐control study of Alzheimer's disease in Australia. Neurology. 1990; 40(11): 1698-707. [DOI:10.1212/WNL.40.11.1698]

22. Zalsman G, Aizenberg D, Sigler M, Nahshony E, Karp L, Weizman A. Increased risk for dementia in elderly psychiatric inpatients with late-onset major depression. J Nerv Ment Dis. 2000; 188(4): 242-3. [DOI:10.1097/00005053-200004000-00010]

23. Petersen R. Mild cognitive impairment: current research and clinical implications. Seminars in Neurology. 2007; 27(1): 022-031. [DOI:10.1055/s-2006-956752]

24. Paterniti S, Verdier-Taillefer M, Dufouil C, Alpérovitch A. Depressive symptoms and cognitive decline in elderly people. Br J Psychiatry. 2002; 181: 406-10. [DOI:10.1192/bjp.181.5.406]

25. Solfrizzi V, D'Introno A, Colacicco A, Capurso C, Del Parigi A, Caselli R, et al. Incident occurrence of depressive symptoms among patients with mild cognitive impairment - the italian longitudinal study on aging. Dement Geriatr Cogn Disord. 2007; 24(1): 55-64. [DOI:10.1159/000103632]

26. Liao W, Zhang X, Shu H, Wang Z, Liu D, Zhang Z. The characteristic of cognitive dysfunction in remitted late life depression and amnestic mild cognitive impairment. Psychiatry Res. 2017; 251: 168-75. [DOI:10.1016/j.psychres.2017.01.024]

27. Vander Mussele S, Fransen A. Depression in mild cognitive impairment is associated with progression to Alzheimer disease: A longtitual study. J Alzhimer Dis. 2014; 42(4): 1239-50. [DOI:10.3233/JAD-140405]

28. Makizako H, Shimada H, Doi T, Tsutsumimoto K, Hotta R, Nakakubo S, et al. Comorbid mild cognitive impairment and depressive symptoms predict future dementia in community older adults: a 24-month follow-up longitudinal study. J Alzheimers Dis. 2016; 54(4): 1473-82. [DOI:10.3233/JAD-160244]

29. Ugtenburg A, Zuidersma M, Voshaar R, Schoevers R. Symptom dimensions of depression and 3-year incidence of dementia. results from the amsterdam study of the elderly (Amstel). The American Journal of Geriatric Psychiatry. 2014; 22(3): S65. [DOI:10.1016/j.jagp.2013.12.069]

30. Tsai SW, Chan YC, Liang F, Hsu CY, Lee IT. Brain-derived neurotrophic factor correlated with muscle strength in subjects undergoing stationary bicycle exercise training. J Diabetes Complications. 2015; 29(3): 367-71. [DOI:10.1016/j.jdiacomp.2015.01.014]

31. Geerlings M, den Heijer T, Koudstaal P, Hofman A, Breteler M. History of depression, depressive symptoms, and medial temporal lobe atrophy and the risk of Alzheimer disease. Neurology. 2008; 70(15): 1258-64. [DOI:10.1212/01.wnl.0000308937.30473.d1]

32. Nascimento K, Silva K, Malloy-Diniz L, Butters M, Diniz B. Plasma and cerebrospinal fluid amyloid-β levels in late-life depression: A systematic review and meta-analysis. J Psychiatr Res. 2015; 69: 35-41. [DOI:10.1016/j.jpsychires.2015.07.024]

33. Leonard BE. Inflammation and depression: a causal or coincidental link to the pathophysiology? Acta Neuropsychiatr. 2018; 30(1): 1-6. [DOI:10.1017/neu.2016.69]

34. Sotiropoulos I, Cerqueira JJ, Catania C, Takashima A, Sousa N, Almeida OF. Stress and glucocorticoid footprints in the brain-the path from depression to Alzheimer's disease. Neurosci Biobehav Rev. 2008; 32(6): 1161-73. [DOI:10.1016/j.neubiorev.2008.05.007]

35. Taylor W, McQuoid D, Payne M, Zannas A, MacFall J, Steffens D. Hippocampus atrophy and the longitudinal course of late-life depression. Am J Geriatr Psychiatry. 2014; 22(12): 1504-12. [DOI:10.1016/j.jagp.2013.11.004]

36. Stratmann M, Konrad C, Kugel H, Krug A, Schöning S, Ohrmann P, et al. Insular and hippocampal gray matter volume reductions in patients with major depressive disorder. PLoS One. 2014; 9(7): e102692. doi: 10.1371/journal.pone.0102692. [DOI:10.1371/journal.pone.0102692]

37. Sheline Y, Gado M, Kraemer H. Untreated depression and hippocampal volume loss. Am J Psychiatry. 2003; 160(8): 1516-8. [DOI:10.1176/appi.ajp.160.8.1516]

38. Stefens DC. Change in hippocampal volume on magnetic resonance imaging and cognitive decline among older depressed patiants. Am J Griatr Psychiatry. 2011; 19(1): 4-12. [DOI:10.1097/JGP.0b013e3181d6c245]

39. Ezzati A, Zimmerman M, Katz M, Lipton R. Hippocampal correlates of depression in healthy elderly adults. Hippocampus. 2013; 23(12): 1137-42. [DOI:10.1002/hipo.22185]

40. Joko T, Washizuka S, Sasayama D, Inuzuka S, Ogihara T, Yasaki T, et al. Patterns of hippocampal atrophy differ among Alzheimer's disease, amnestic mild cognitive impairment, and late-life depression. Psychogeriatrics. 2016; 16(6): 355-61. [DOI:10.1111/psyg.12176]

41. Tapia-Arancibia L, Aliaga E, Silhol M, Arancibia S. New insights into brain BDNF function in normal aging and Alzheimer disease. Brain Research Reviews. 2008; 59(1): 201-20. [DOI:10.1016/j.brainresrev.2008.07.007]

42. Hashizume M, Hachisu M, Yoshida H, Kim M, Kim H, Amano Y, et al. Serum brain-derived neurotrophic factor level in elderly women depression: A community-based study. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2015; 56: 109-16. [DOI:10.1016/j.pnpbp.2014.08.012]

43. Diniz B, Reynolds C, Begley A, Dew M, Anderson S, Lotrich F, et al. Brain-derived neurotrophic factor levels in late-life depression and comorbid mild cognitive impairment: A longitudinal study. Journal of Psychiatric Research. 2014; 49: 96-101. [DOI:10.1016/j.jpsychires.2013.11.004]

44. McKinney BC, Sibille E. The age-by-disease interaction hypothesis of late-life depression. American Journal of Geriatric Psychiatry. 2013; 21(5): 418-32. [DOI:10.1016/j.jagp.2013.01.053]

45. Bell-McGinty S, Butters M, Meltzer C, Greer P, Reynolds C, Becker J. Brain morphometric abnormalities in geriatric depression: long-term neurobiological effects of illness duration. American Journal of Psychiatry. 2002; 159(8): 1424-7. [DOI:10.1176/appi.ajp.159.8.1424]

46. Forlenza OV, Diniz B, Gattaz W. Diagnosis and biomarkers of predementia in Alzheimer's disease. BMC Medicine. 2010; 8(1). [DOI:10.1186/1741-7015-8-89]

47. Praag H, Kloet E, Os J. Stress, the brain and depression. Cambridge: Cambridge University Press. 2012.

48. Sapolesky RM, Krey LC. The neuroendocrinology of stress and aging. Endocr Rev. 1986; 7: 284-301. [DOI:10.1210/edrv-7-3-284]

49. Fahim S, Van Djin CM. A study of familial aggregation of depression, dementia and Parkinson disease. Eur J Epidepological. 1998; 14(3): 233-8. [DOI:10.1023/A:1007488902983]

50. Krishnan KR, Tupler LA, Ritchie JC, McDonald WM, Knight DL, Nemeroff CB, et al. Apolipoprotein E-ε4 frequency in geriatric depression. Biological Psychiatry. 1996; 40(1): 69-71. [DOI:10.1016/0006-3223(95)00424-6]

51. Kim DH, Payen ME, Levy RM. APOE genotype and hippocampal volume change in geriatric depression. Biol Psychiatry. 2002; 51(5): 426-9. [DOI:10.1016/S0006-3223(01)01272-0]

52. Scarmeas N, Stern Y. Cognitive reserve: implications for diagnosis and prevention of Alzheimer's disease. Current Neurology and Neuroscience Reports. 2004; 4(5): 374-80. [DOI:10.1007/s11910-004-0084-7]

53. Paillard T, Rolland Y, de Souto Barreto P. Protective effects of physical exercise in alzheimer's disease and parkinson's disease: a narrative review. J Clin Neurol. 2015; 11(3): 212-9. [DOI:10.3988/jcn.2015.11.3.212]